# GENINUS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/geninus

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.kr-geninus.com
- Total disclosed funding: $20M
- Latest round: Series B (Aug 12, 2020)
- Investors on record: 7

## About

Based in South Korea, GENINUS Inc. operates as a biotechnology firm specializing in advanced genetic analysis, utilizing multi-omics technology to provide insights for healthcare and research sectors.Founded in 2018 and headquartered in Seoul, South Korea, GENINUS Inc. focuses on advanced genetic analysis. The company has successfully raised KRW 10,000.00 mn through multiple funding rounds, with the latest being a VENTURE DEBT round of KRW 10,000.00 mn on November 8, 2021. The company’s CEO and founder, Woong-yang Park, has previously been involved in entrepreneurial ventures.GENINUS Inc. specializes in advanced genetic analysis through its innovative product offerings, primarily focusing on multi-omics technology. Their core solutions include IntelliMed™, MEDINSIGHT™, and SPACEINSIGHT™, which provide comprehensive insights into tissue-specific transcriptomes and cellular complexity. IntelliMed™ enhances clinical genomics using clinically annotated single-cell and spatial omics data, while MEDINSIGHT™ incorporates AI-powered digital pathology for faster and more accurate diagnoses. SPACEINSIGHT™ is a cloud-based platform for spatial transcriptomics, enabling interactive data visualization and analysis. Their products serve a diverse clientele including academic institutions, pharmaceutical companies, and healthcare organizations across North America, Europe, and Asia.In the most recent year, 2024, GENINUS Inc. reported a revenue of KRW 4,736.21 mn with an EBITDA of KRW -7,004.85 mn, reflecting ongoing investments in their advanced data analysis platforms and services.GENINUS Inc. plans to expand its market reach by introducing new products designed to enhance their multi-omics technology in 2024. They are targeting expansions into North America and Europe, taking advantage of recent funding from their VENTURE DEBT round in November 2021, where they raised KRW 40 billion. The funding will support product development and enhance market penetration in these regions.

## Funding rounds

- Series B, Aug 12, 2020, $13M — KB Investment, WOORI Venture Partners, Korea Investment Partners, IMM Investment, Company K Partners
- Series A, Apr 5, 2019, $7M — KB Investment, Solidus Investment, Company K Partners
- Seed, Nov 1, 2018 — KB Investment, Solidus Investment, Korea Tech Incubator for Startup

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Seed, Series A, Series B
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Seed, Series A
- Korea Tech Incubator for Startup — Seed
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A, Series B
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series B
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B